Yamauchi Yasushi, Wettergren Andre, Yamashita Yuichi, Mikami Koji, Hyodo Masanobu, Larsen Peter Norgaard, Rasmussen Allan, Shirakusa Takayuki, Kirkegaard Preben
Second Department of Surgery, Fukuoka University School of Medicine, Fukuoka, Japan.
Hepatogastroenterology. 2007 Jun;54(76):1181-6.
BACKGROUND/AIMS: The purpose of this study was to assess the outcome of liver retransplantation in adults at our institution and identify the subset of patients in which the outcome was too poor to justify retransplantation.
Over a 12-year period, we performed 346 liver transplantations in 305 adult patients, and of these, 41 (11.8%) were retransplantations. Survival data were stratified and multivariate analysis was conducted to identify variables associated with poor outcome after retransplantation.
The 90-day, 1-year, and 5-year survival rates after liver retransplantation were 65.9%, 62.6%, and 48.2%, respectively. These rates were significantly inferior compared to those following single liver transplantation. Major adverse events affecting patient survival after retransplantation occurred within the first 90 days after surgery. Three independent prognostic variables of patient survival after retransplantation were identified: preoperative coagulation factor, total bilirubin, and the need for preoperative dialysis. Using these variables, we defined a simplified mathematical model available at the time of decision of retransplantation.
The present study indicated three important prognostic factors associated with a poor outcome after retransplantation. Based on our newly developed scoring-system estimating patient survival, we suggest that retransplantation must be indicated before the deterioration of more than two organs. These findings should assist in the decision process for liver retransplantation in adult patients.
背景/目的:本研究旨在评估我院成人肝脏再次移植的结果,并确定那些预后太差以至于不值得进行再次移植的患者亚组。
在12年期间,我们对305例成年患者进行了346例肝脏移植,其中41例(11.8%)为再次移植。对生存数据进行分层,并进行多变量分析以确定与再次移植后不良预后相关的变量。
肝脏再次移植后的90天、1年和5年生存率分别为65.9%、62.6%和48.2%。这些生存率显著低于首次肝脏移植后的生存率。影响再次移植后患者生存的主要不良事件发生在术后前90天内。确定了再次移植后患者生存的三个独立预后变量:术前凝血因子、总胆红素和术前透析需求。利用这些变量,我们定义了一个在决定再次移植时可用的简化数学模型。
本研究指出了与再次移植后不良预后相关的三个重要预后因素。基于我们新开发的评估患者生存的评分系统,我们建议在超过两个器官功能恶化之前必须进行再次移植。这些发现应有助于成人患者肝脏再次移植的决策过程。